| |
|
|
|
Antares Pharma Inc.  
|
|
3.1 0 (0%) |
07-19 16:00 |
|
Open: |
3.08 |
Pre close: |
3.1 |
Target:
|
3.76
|
|
High: |
3.14 |
Low: |
3.07 |
Resistance:
|
3.22
3.46
|
|
Volume: |
601,503 |
Market Cap: |
504M |
Support:
|
2.82
2.35
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.05
 |
MACD |
MACD(12,26):
|
0.02  |
|
MA(20): |
3.18 |
Signal(12,26,9): |
0.05 |
|
MA(100): |
3.07 |
Stochastic Oscillator |
%K(14,3):
|
31.55 |
|
MA(250): |
3.16 |
%D(3): |
24.74 |
|
Average Volume(K) |
3-Month: |
115116
|
52-Week |
High:
|
3.96 |
|
10-Days: |
111589 |
Low: |
2.53 |
|
RSI |
RSI(14):
|
49.51 |
Change(%): |
11.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.037 |
Return on Equity (ttm) |
-16.5 |
Shares Out. (M) |
162.62 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
-11.7 |
Shares Float (M) |
139.73 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
-0.43 |
% Held by Insiders |
7.34 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
83.3 |
% Held by Institutions |
42.29 |
|
Forward EPS |
0.050 |
Gross Profit (p.s.) |
0.200 |
Shares Short (K) |
8060 |
|
Book Value (p.s.) |
0.260 |
EBITDA (p.s.) |
-0.081 |
P/E |
-83.78 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
11.92 |
|
Profit Margin |
-7.91 |
Operating Cash Flow
(M) |
-23.28 |
P/S |
1072599936.00 |
|
Operating Margin |
-21.53 |
Levered Free Cash Flow
(M) |
-25.16 |
P/CF |
-21.65 |
|
|
|
|
|
|
